The NTHL1 gene helps repair small, everyday damage in DNA, which supports healthy cell growth. If it does not work properly, DNA changes can build up over time. Many variants are harmless, while a few may change how the gene works. People with pathogenic variants in both copies can develop many colon polyps and have a higher chance of colorectal cancer and some other cancers. The NTHL1 gene is mainly known in genetics clinics rather than in popular culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Others mainly help control when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
NTHL1Gene function
What if the gene works
The NTHL1 gene helps cells repair small types of DNA damage that build up during normal daily wear. This supports stable genetic information and healthy cell growth.
Risk
What if the gene does not work
More disruptive variants in both copies of the NTHL1 gene can cause NTHL1 tumor syndrome, often with many colon polyps and higher risks of colorectal, breast, and other cancers. Milder variants may have less predictable effects.
Treatment
What does that mean for your treatment
For people with two pathogenic variants in the NTHL1 gene, care is guided mainly by polyp burden and any cancers found. Management usually includes regular colonoscopy with polyp removal, and surgery may be considered if polyps cannot be controlled this way. No NTHL1-specific medication or targeted drug choice is currently established in guidelines.
Conditions associated with NTHL1
Gene function
What if the gene works
Every day, your cells pick up small bits of DNA wear from normal metabolism. The NTHL1 gene helps repair oxidative DNA damage by finding and starting the cleanup of some of these changes. This everyday work supports healthy cell maintenance across the body.
Its protein scans DNA for certain damaged DNA letters that can appear during normal cell activity. This helps cells spot wear early as part of routine DNA maintenance.
After finding damage, its protein removes the altered DNA letter as part of base excision repair (a routine DNA cleanup pathway). This opens the way for other repair proteins to fill in the correct letter.
By clearing everyday DNA damage, the NTHL1 gene supports stable genetic instructions over time. This steady maintenance is part of the NTHL1 gene's role in DNA repair during normal cell growth and renewal.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In the NTHL1 gene, variants can change the protein’s shape or cut it short, which may weaken how NTHL1 gene variants affect DNA repair in cells. Some variants leave partial activity, while more severe variants can cause little or no working protein. When both copies are markedly affected, DNA errors can build up more easily, which is linked to polyps and cancers and may influence how early they appear.
How variants are linked to conditions
People who inherit harmful variants in both copies of the NTHL1 gene can develop NTHL1 tumor syndrome, an inherited condition linked to multiple colon polyps and a raised chance of colorectal cancer. NTHL1 gene variants are also associated with a higher chance of other cancers, especially breast and endometrial cancer, and sometimes cancers in other organs. Carrying one altered copy has not shown the same clear, well-established risk pattern.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NTHL1, the main factor is whether someone has harmful changes in both copies of the gene, which can greatly raise the chance of colon polyps, bowel cancer, and some other cancers. Family history and whether polyps or cancers have already appeared can also shape how this risk is managed over time.
Inheritance of NTHL1 variants
Variants linked to NTHL1-related tumor syndrome are inherited in an autosomal recessive pattern. This means a person usually inherits one altered copy of the NTHL1 gene from each parent, and both parents are often healthy carriers. When both parents carry a variant in the NTHL1 gene, each child has a 25% chance of inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant.
What does my NTHL1 result mean for my family?
For NTHL1, family implications are usually linked to a recessive pattern, which means close relatives may also carry the same gene change even if they have never had cancer. Brothers and sisters may have a higher chance of having the same result, and children are usually carriers unless the other parent also carries an NTHL1 change. Because of this, relatives may want to talk with their doctor or a genetic counselor about whether family testing makes sense.
Genetic information
Genetic testing
How you find out about variants
You find out about changes in the NTHL1 gene through NTHL1 genetic testing, usually done on a blood or saliva sample. The lab reads the gene’s DNA sequence to look for variants, often as part of a larger inherited cancer panel, and the results can show whether one or both copies carry a clinically important variant.
When should I consider getting a genetic test?
Genetic testing for the NTHL1 gene may be worth considering if you or close relatives have had many colon polyps, colorectal cancer, or a pattern of several cancers in the same family. It can also help explain why these cancers run together, especially when standard testing has not found another cause.
A genetic result is only one part of your health story
Genetic findings can be informative, yet how much they reveal depends on the condition and on the specific kind of variant. How your body works over time is also shaped by many other factors, including age, lifestyle, environment, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results may help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes that help process drugs or influence how medicines act in the body can change how much of a drug is active at one time. This is common and can help explain why the same treatment works well for one person but less well for another, or why some people are more sensitive to side effects. Medication response is also shaped by age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By studying links between genes and drugs, it helps explain why the same treatment may not work the same way for everyone. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed, personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the NTHL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. If you have concerns about side effects, how well a treatment is working, or how your medicines may interact, discuss them with your doctor.
History
NTHL1 entered human genetics through research on how cells fix everyday DNA damage, with early work identifying it as the human counterpart of a repair gene first studied in bacteria. Initially understood only through laboratory studies, later recognized as tied to a specific gene change pattern seen in some families with many colon polyps and colorectal cancer. In 2015, researchers reported that having disease causing variants in both copies of the NTHL1 gene could underlie a hereditary cancer condition now called NTHL1 tumor syndrome. From these first observations, research expanded steadily. Later studies linked this syndrome to a broader range of cancers, which helped define the condition more clearly. Over time, descriptions became more precise as genetic testing made it easier to recognize affected families.